Cite
HARVARD Citation
Katodritou, E. et al. (2023). Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group. American journal of hematology. 98 (5), pp. 730-738. [Online].